Hensen, Marja; Heeg, Bart; Löthgren, Mickael; Hout, Ben - In: Applied Health Economics and Health Policy 8 (2010) 5, pp. 327-341
Treatment with RLAI is suggested to result in improved QALYs combined with cost savings compared with haloperidol LAI among the Swedish, high-risk non-compliant schizophrenia patient population. In the general schizophrenia population, RLAI also resulted in positive incremental QALYs and cost...